Literature DB >> 23253762

From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.

Mitchell J Warren1, Emily S Bass.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23253762     DOI： 10.1016/j.amepre.2012.10.006

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN： 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  6 in total

Review 1.  Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Authors:  Jared M Baeten; Jessica E Haberer; Albert Y Liu; Nirupama Sista
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

2.  High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.

Authors:  Stephanie E Cohen; Eric Vittinghoff; Oliver Bacon; Susanne Doblecki-Lewis; Brian S Postle; Daniel J Feaster; Tim Matheson; Nikole Trainor; Robert W Blue; Yannine Estrada; Megan E Coleman; Richard Elion; Jose G Castro; Wairimu Chege; Susan S Philip; Susan Buchbinder; Michael A Kolber; Albert Y Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

3.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

Review 4.  Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Authors:  Jennifer L Brown; Jessica M Sales; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

5.  Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.

Authors:  Zhao Ni; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver; Elizabeth E DiDomizio; LaRon E Nelson; Roman Shrestha
Journal:  Drug Alcohol Depend       Date:  2021-01-07       Impact factor: 4.492

6.  Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013.

Authors:  Erin C Wilson; Harry Jin; Albert Liu; H Fisher Raymond
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.